Literature DB >> 17533514

The effect of substitution of the N-acetyl groups of N-acetylgalactosamine residues in chondroitin sulfate on its degradation by chondroitinase ABC.

Subbarao V Madhunapantula1, Rajeshwara N Achur, Veer P Bhavanandan, D Channe Gowda.   

Abstract

Chondroitinase ABC is a lyase that degrades chondroitin sulfate, dermatan sulfate and hyaluronic acid into disaccharides. The purpose of this study was to determine the ability of chondroitinase ABC to degrade chondroitin sulfate in which the N-acetyl groups are substituted with different acyl groups. The bovine tracheal chondroitin sulfate A (bCSA) was N-deacetylated by hydrazinolysis, and the free amino groups derivatized into N-formyl, N-propionyl, N-butyryl, N-hexanoyl or N-benzoyl amides. Treatment of the N-acyl or N-benzoyl derivatives of bCSA with chondroitinase ABC and analysis of the products showed that the N-formyl, N-hexanoyl and N-benzoyl derivatives are completely resistant to the enzyme. In contrast, the N-propionyl or N-butyryl derivatives were degraded into disaccharides with slower kinetics compared to that of unmodified bCSA. The rate of degradation of bCSA derivatives by the enzyme was found to be in the order of N-acetyl>N-propionyl>>N-butyryl bCSA. These results have important implications for understanding the interaction of N-acetyl groups of glycosaminoglycans with chondroitinase ABC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17533514     DOI: 10.1007/s10719-007-9039-y

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  36 in total

Review 1.  Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate.

Authors:  Kazuyuki Sugahara; Tadahisa Mikami; Toru Uyama; Souhei Mizuguchi; Kazuya Nomura; Hiroshi Kitagawa
Journal:  Curr Opin Struct Biol       Date:  2003-10       Impact factor: 6.809

Review 2.  Biosynthesis and interactions of small chondroitin/dermatan sulphate proteoglycans.

Authors:  H Kresse; H Hausser; E Schönherr; K Bittner
Journal:  Eur J Clin Chem Clin Biochem       Date:  1994-04

3.  Structural analysis of chick-embryo cartilage proteoglycan by selective degradation with chondroitin lyases (chondroitinases) and endo-beta-D-galactosidase (keratanase).

Authors:  Y Oike; K Kimata; T Shinomura; K Nakazawa; S Suzuki
Journal:  Biochem J       Date:  1980-10-01       Impact factor: 3.857

4.  Preparation and fractionation of glycopeptides.

Authors:  J Finne; T Krusius
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

5.  Structural basis for the adherence of Plasmodium falciparum-infected erythrocytes to chondroitin 4-sulfate and design of novel photoactivable reagents for the identification of parasite adhesive proteins.

Authors:  A S Prakasha Gowda; SubbaRao V Madhunapantula; Rajeshwara N Achur; Manojkumar Valiyaveettil; Veer P Bhavanandan; D Channe Gowda
Journal:  J Biol Chem       Date:  2006-11-03       Impact factor: 5.157

6.  Hydrazinolysis of heparin and other glycosaminoglycans.

Authors:  P N Shaklee; H E Conrad
Journal:  Biochem J       Date:  1984-01-01       Impact factor: 3.857

7.  Immunological determinants of proteoglycans. Antibodies against the unsaturated oligosaccharide products of chondroitinase ABC-digested cartilage proteoglycans.

Authors:  J E Christner; B Caterson; J R Baker
Journal:  J Biol Chem       Date:  1980-08-10       Impact factor: 5.157

Review 8.  The pathobiology of osteoarthritis and the rationale for using the chondroitin sulfate for its treatment.

Authors:  Nicola Volpi
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2004-06

9.  Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta.

Authors:  M Fried; P E Duffy
Journal:  Science       Date:  1996-06-07       Impact factor: 47.728

Review 10.  Involvement of stromal proteoglycans in tumour progression.

Authors:  Yanusz Wegrowski; Francois-Xavier Maquart
Journal:  Crit Rev Oncol Hematol       Date:  2004-03       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.